Impact of diabetes on clinical outcomes after revascularization with sirolimus-eluting and biolimus-eluting stents with biodegradable polymer from the SORT OUT VII trial.

Julia EllertEvald Høj ChristiansenMichael MaengBent RaungaardSvend Eggert JensenSteen Dalby KristensenKarsten Tange VeienAnders Bo JunkerLars JakobsenJens AarøeChristian Juhl TerkelsenJohnny KahlertAnton Boel VilladsenHans Erik BøtkerLisette Okkels Jensen

Published in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2018)

TLF did not differ between O-SES- and N-BES-treated diabetic patients.

Keyphrases

type diabetes
drug delivery
phase iii
cardiovascular disease
study protocol
glycemic control
phase ii
percutaneous coronary intervention
clinical trial
coronary artery bypass grafting
randomized controlled trial
open label
newly diagnosed
metabolic syndrome
atrial fibrillation